SCHEMBL7049348

SCHEMBL7049348

CC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1cccc(OCc2ccc([N+](=O)[O-])cc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.60
MAOA P21397 1/20 0.60
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
MAPT P10636 5/20 0.55
LMNA P02545 3/20 0.50
GAA P10253 2/20 0.49
HPGD P15428 1/20 0.49
ALDH1A1 P00352 4/20 0.48
TP53 P04637 1/20 0.48
HTT P42858 2/20 0.47
MAPK1 P28482 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSP90AA1 P07900 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TSHR P16473 1/20 0.47
BCL2L1 Q07817 1/20 0.46
MCL1 Q07820 1/20 0.46
FFAR1 O14842 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7076437 0.90 MEN1 (0.56) MAOBMAOAMEN1KMT2AMAPT
SCHEMBL7045371 0.90 KMT2A (0.62) MAOBMEN1KMT2AMAPTLMNA
SCHEMBL7047639 0.87 MAOB (0.52) MAOBMAOAMEN1KMT2AMAPT
SCHEMBL7048385 0.87 MAOA (0.57) MAOBMAOAMEN1KMT2AGAA
SCHEMBL7048265 0.87 SMPD1 (0.60) MEN1KMT2AMAPTLMNAGAA
SCHEMBL7048363 0.87 MAOB (0.59) MAOBMAOAMEN1KMT2AMAPT
SCHEMBL7051022 0.87 MAOB (0.51) MAOBMAOAMEN1KMT2AMAPT
SCHEMBL7048541 0.86 NR4A1 (0.57) MAOBMEN1KMT2AMAPTGAA
SCHEMBL7080255 0.86 MAPT (0.58) MAOBMAOAMEN1KMT2AMAPT
SCHEMBL7047622 0.84 MAOB (0.60) MAOBMEN1KMT2AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN MAOB 396/4885MAOA 591/4885MEN1 4502/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 MAOB 2736/4885MAOA 2901/4885MEN1 3302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.